Stage IA Breast Cancer Active Not Recruiting Phase 3 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0029217 (Stage IA Breast Cancer)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00433511Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast CancerTreatment